Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MDWD
STRONG SELLMediWound Ltd. · Healthcare · Israel · $183M · Avg Vol: $1M/d
8
StockRankGet insider-trade alerts
Q
21
V
26
M
34
P/E (TTM)
—
ROE
-71.8%
D/E
0.2x
Dividend %
—
COMPANY DESCRIPTION
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.5M | 18.7M | 20.2M | 17.0M | -13.8% | 14.5M | 24.1M | 32.9M | 39.2% |
| EPS | -3.93 | -0.75 | -3.03 | -2.10 | — | -2.26 | -2.39 | -2.22 | — |
| Shares | 7.2M | 9.2M | 10.8M | 12.8M | +77.3% | 12.9M | — | — | — |
| Debt | 0.8M | 6.3M | 6.5M | 8.2M | 112.8% | 8.1M | — | — | — |
| Equity | 10.9M | 31.6M | 31.2M | 43.6M | 58.7% | — | — | — | — |
| Op CF | -11.9M | -10.5M | -13.6M | -16.1M | — | -18.8M | — | — | — |
| Inv CF | -0.5M | -34.3M | -8.4M | -17.9M | — | — | — | — | — |
| Fin CF | 35.8M | 22.9M | 19.4M | 29.6M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-5.3%
SMA 50SMA 200
Close
$14.39
RSI (14)
44.9
52W High
$20.30
From 52W High
0.7%
SCORE BREAKDOWN
Quality
21
ROIC
-43.1%18.1
ROE
-71.8%13.0
GP/Assets
3.3%17.1
Op. Margin
-541.0%10.3
FCF/Assets
-29.1%12.2
Piotroski
431.8
Int. Cover
-50.0x6.4
D/E Ratio
0.20x50.3
Current Ratio
2.41x45.9
Value
26
P/E (TTM)
—N/A
EV/EBITDA
-5.4x25.0
P/FCF
—N/A
P/B
4.4x31.2
P/S
12.6x23.2
Div Yield
—N/A
Momentum
34
52W High %
71%52.1
RS 6M
-31%27.5
SMA 50/200
0.86x30.7
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+2%22.2
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$183M
P/E (Forward)
-6.4x
Gross Margin
19.6%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MDWD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MDWD | MediWound Ltd.(you) | $183M | 8 | STRONG SELL |
| ENTX | Entera Bio Ltd. | $101M | 16 | STRONG SELL |
| ENLV | Enlivex Ltd. | $71M | 12 | STRONG SELL |
| PYPD | PolyPid Ltd. | $75M | 22 | SELL |
| SLGL | Sol-Gel Technologies Ltd. | $268M | 34 | SELL |
| DRTS | Alpha Tau Medical Ltd. | $1.1B | 27 | SELL |
| CGEN | Compugen Ltd. | $216M | 86 | STRONG BUY |
| NNOX | Nano-X Imaging Ltd. | $62M | 5 | STRONG SELL |
| INCR | InterCure Ltd. | $55M | 37 | HOLD |
| BVC.L | BATM Advanced Communications Ltd. | $67M | 53 | HOLD |
Peer medians: ROE 5.1% · P/E 16.0x · Gross margin 32.5%